CYTEK BIOSCIENCES, INC. Temporary Equity, Foreign Currency Translation Adjustments
CYTEK BIOSCIENCES, INC. (CTKB) reported Temporary Equity, Foreign Currency Translation Adjustments of $517.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2026-06-30 was $517.00K, a 14.26% decline year-over-year.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2026-03-31 was $328.00K.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2025-09-30 was $741.00K, a 633.66% increase year-over-year.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2025-06-30 was $603.00K, a 56.15% decline year-over-year.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for fiscal 2025 was $2.17M, a 81.64% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for fiscal 2024 was $1.19M.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for fiscal 2023 was -$549.00K.
- CYTEK BIOSCIENCES, INC. temporary equity, foreign currency translation adjustments for fiscal 2022 was -$1.61M, a 293.63% decline from fiscal 2021.
| Period end | Temporary Equity, Foreign Currency Translation Adjustments 3 month | Temporary Equity, Foreign Currency Translation Adjustments 6 month | Temporary Equity, Foreign Currency Translation Adjustments 9 month | Temporary Equity, Foreign Currency Translation Adjustments 12 month | Temporary Equity, Foreign Currency Translation Adjustments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $517.00K 10-Q · filed 2026-08-05 | $845.00K derived: sum of 2 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $328.00K 10-Q · filed 2026-08-05 | ||||
| 2025-12-31 | $2.17M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $741.00K 10-Q · filed 2025-11-05 | $1.34M derived: sum of 2 quarters · filed 2026-08-05 | $784.00K derived: sum of 3 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $603.00K 10-Q · filed 2026-08-05 | $43.00K derived: sum of 2 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$560.00K 10-Q · filed 2026-08-05 | ||||
| 2024-12-31 | $1.19M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $101.00K 10-Q · filed 2025-11-05 | $1.48M derived: sum of 2 quarters · filed 2025-11-05 | $1.23M derived: sum of 3 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $1.38M 10-Q · filed 2025-11-05 | $1.13M derived: sum of 2 quarters · filed 2025-11-05 | |||
| 2024-03-31 | -$244.00K 10-Q · filed 2025-11-05 | ||||
| 2023-12-31 | -$549.00K 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $165.00K 10-Q · filed 2024-11-07 | -$815.00K derived: sum of 2 quarters · filed 2024-11-07 | -$857.00K derived: sum of 3 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$980.00K 10-Q · filed 2024-11-07 | -$1.02M derived: sum of 2 quarters · filed 2024-11-07 | |||
| 2023-03-31 | -$42.00K 10-Q · filed 2024-11-07 | ||||
| 2022-12-31 | -$1.61M 10-K · filed 2025-02-28 | $1.61M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$758.00K 10-Q · filed 2023-11-14 | -$1.44M derived: sum of 2 quarters · filed 2023-11-14 | -$1.43M derived: sum of 3 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$683.00K 10-Q · filed 2023-11-14 | -$669.00K derived: sum of 2 quarters · filed 2023-11-14 | |||
| 2022-03-31 | $14.00K 10-Q · filed 2023-11-14 | ||||
| 2021-12-31 | $832.00K 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $34.00K 10-Q · filed 2022-11-09 | $303.00K derived: sum of 2 quarters · filed 2022-11-09 | $505.00K derived: sum of 3 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $269.00K 10-Q · filed 2022-11-09 | $471.00K derived: sum of 2 quarters · filed 2022-11-09 | |||
| 2021-03-31 | $202.00K 10-Q · filed 2022-11-09 | ||||
| 2020-12-31 | $212.00K 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $145.00K 10-Q · filed 2021-11-12 | $126.00K derived: sum of 2 quarters · filed 2021-11-12 | $49.00K derived: sum of 3 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$19.00K 10-Q · filed 2021-11-12 | -$96.00K derived: sum of 2 quarters · filed 2021-11-12 | |||
| 2020-03-31 | -$77.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |